166 related articles for article (PubMed ID: 24133921)
1. The diagnostic efficacy of urinary survivin and hyaluronidase mRNA as urine markers in patients with bladder cancer.
Eissa S; Badr S; Barakat M; Zaghloul AS; Mohanad M
Clin Lab; 2013; 59(7-8):893-900. PubMed ID: 24133921
[TBL] [Abstract][Full Text] [Related]
2. The value of combined use of survivin mRNA and matrix metalloproteinase 2 and 9 for bladder cancer detection in voided urine.
Eissa S; Badr S; Elhamid SA; Helmy AS; Nour M; Esmat M
Dis Markers; 2013; 34(1):57-62. PubMed ID: 22960341
[TBL] [Abstract][Full Text] [Related]
3. Expression of HYAL1 and survivin RNA as diagnostic molecular markers for bladder cancer.
Eissa S; Swellam M; Shehata H; El-Khouly IM; El-Zayat T; El-Ahmady O
J Urol; 2010 Feb; 183(2):493-8. PubMed ID: 20006858
[TBL] [Abstract][Full Text] [Related]
4. Detection of bladder carcinoma by combined testing of urine for hyaluronidase and cytokeratin 20 RNAs.
Eissa S; Kassim SK; Labib RA; El-Khouly IM; Ghaffer TM; Sadek M; Razek OA; El-Ahmady O
Cancer; 2005 Apr; 103(7):1356-62. PubMed ID: 15717321
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic value of urine-based survivin mRNA test using reverse transcription-polymerase chain reaction for bladder cancer: a systematic review.
Xia Y; Liu YL; Yang KH; Chen W
Chin J Cancer; 2010 Apr; 29(4):441-6. PubMed ID: 20346223
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis.
Weikert S; Christoph F; Schrader M; Krause H; Miller K; Müller M
Int J Cancer; 2005 Aug; 116(1):100-4. PubMed ID: 15761870
[TBL] [Abstract][Full Text] [Related]
7. The value of combined use of survivin, cytokeratin 20 and mucin 7 mRNA for bladder cancer detection in voided urine.
Pu XY; Wang ZP; Chen YR; Wang XH; Wu YL; Wang HP
J Cancer Res Clin Oncol; 2008 Jun; 134(6):659-65. PubMed ID: 18026991
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia inducible factor-1alpha and microvessel density as angiogenic factors in bilharzial and non-bilharzial bladder cancer.
Badr S; Salem A; Yuosif AH; Awadallah H; Awed N; Bakr A
Clin Lab; 2013; 59(7-8):805-12. PubMed ID: 24133909
[TBL] [Abstract][Full Text] [Related]
9. Value of urinary survivin as a diagnostic marker in bladder cancer.
Abd El-Hakim TF; El-Shafie MK; Abdou AG; Azmy RM; El-Naidany SS; Badr El-Din MO
Anal Quant Cytopathol Histpathol; 2014 Jun; 36(3):121-7. PubMed ID: 25141488
[TBL] [Abstract][Full Text] [Related]
10. [Value of combined detection of urinary Livin and Survivin mRNA expression in the early diagnosis of bladder cancer].
Jiang LL; Xie MM; Wang XR; Zhao Y; Wang ZJ
Zhonghua Yi Xue Za Zhi; 2013 Nov; 93(44):3520-2. PubMed ID: 24521893
[TBL] [Abstract][Full Text] [Related]
11. [Usefulness of survivin/glyceraldehyde-3-phosphate dehydrogenase ratio in urine exfoliated cells for the detection of bladder tumor].
Sakamoto Y; Nishioka J; Noma K; Yasuda K; Nakatani K; Kise H; Sugimura Y; Nobori T
Rinsho Byori; 2011 May; 59(5):446-51. PubMed ID: 21706857
[TBL] [Abstract][Full Text] [Related]
12. Detection of hyaluronidase RNA and activity in urine of schistosomal and non-schistosomal bladder cancer.
Eissa S; Shehata H; Mansour A; Esmat M; El-Ahmady O
Med Oncol; 2012 Dec; 29(5):3345-51. PubMed ID: 22760792
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of urinary human telomerase reverse transcriptase mRNA and scatter factor protein as urine markers for diagnosis of bladder cancer.
Eissa S; Motawi T; Badr S; Zaghlool A; Maher A
Clin Lab; 2013; 59(3-4):317-23. PubMed ID: 23724620
[TBL] [Abstract][Full Text] [Related]
14. Comparison of CD44 and cytokeratin 20 mRNA in voided urine samples as diagnostic tools for bladder cancer.
Eissa S; Zohny SF; Swellam M; Mahmoud MH; El-Zayat TM; Salem AM
Clin Biochem; 2008 Nov; 41(16-17):1335-41. PubMed ID: 18804101
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic evaluation of apoptosis inhibitory gene and tissue inhibitor matrix metalloproteinase-2 in patients with bladder cancer.
Eissa S; Shabayek MI; Ismail MF; El-Allawy RM; Hamdy MA
IUBMB Life; 2010 May; 62(5):394-9. PubMed ID: 20408180
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of survivin reverse transcriptase-polymerase chain reaction for noninvasive detection of bladder cancer.
Moussa O; Abol-Enein H; Bissada NK; Keane T; Ghoneim MA; Watson DK
J Urol; 2006 Jun; 175(6):2312-6. PubMed ID: 16697865
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of hTERT, KRT7, and survivin in urine for noninvasive detection of bladder cancer using real-time PCR.
Yahyazadeh R; Bashash D; Ghaffari P; Kord S; Safaroghli-Azar A; Ghaffari SH
BMC Urol; 2021 Apr; 21(1):64. PubMed ID: 33874920
[TBL] [Abstract][Full Text] [Related]
18. [Expression of survivin mRNA in urine exfoliated cells of patients with bladder transitional cell carcinoma detected by real-time PCR].
Sun J; Hou JQ; He J; He XF; Wen DG
Ai Zheng; 2009 Oct; 28(10):1100-2. PubMed ID: 19799821
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic value of bladder cancer-related transcript markers in urine.
Schmidt J; Propping C; Siow WY; Lohse-Fischer A; Toma M; Baldauf-Twelker A; Hakenberg OW; Wirth MP; Fuessel S
J Cancer Res Clin Oncol; 2016 Feb; 142(2):401-14. PubMed ID: 26328914
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic role of survivin in urinary bladder cancer.
Srivastava AK; Singh PK; Srivastava K; Singh D; Dalela D; Rath SK; Goel MM; Brahma Bhatt ML
Asian Pac J Cancer Prev; 2013; 14(1):81-5. PubMed ID: 23534808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
